Jim Cramer Recommends Pharmaceutical Giants as Non-Tech Innovation Plays

Financial commentator Jim Cramer has identified pharmaceutical giants like Johnson & Johnson (JNJ) and Eli Lilly (LLY) as strong investment opportunities. He highlights these companies as innovative plays outside the traditional technology sector.